Literature DB >> 19660547

Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.

M E Emborg1, J Moirano, J Raschke, V Bondarenko, R Zufferey, S Peng, A D Ebert, V Joers, B Roitberg, J E Holden, J Koprich, J Lipton, J H Kordower, P Aebischer.   

Abstract

This study assessed the potential for functional and anatomical recovery of the diseased aged primate nigrostriatal system, in response to trophic factor gene transfer. Aged rhesus monkeys received a single intracarotid infusion of MPTP, followed one week later by MRI-guided stereotaxic intrastriatal and intranigral injections of lentiviral vectors encoding for glial derived neurotrophic factor (lenti-GDNF) or beta-galactosidase (lenti-LacZ). Functional analysis revealed that the lenti-GDNF, but not lenti-LacZ treated monkeys displayed behavioral improvements that were associated with increased fluorodopa uptake in the striatum ipsilateral to lenti-GDNF treatment. GDNF ELISA of striatal brain samples confirmed increased GDNF expression in lenti-GDNF treated aged animals that correlated with functional improvements and preserved nigrostriatal dopaminergic markers. Our results indicate that the aged primate brain challenged by MPTP administration has the potential to respond to trophic factor delivery and that the degree of neuroprotection depends on GDNF levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660547      PMCID: PMC2989601          DOI: 10.1016/j.nbd.2009.07.022

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  68 in total

1.  Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.

Authors:  Timothy J Collier; Jack Lipton; Brian F Daley; Stephane Palfi; Yaping Chu; Caryl Sortwell; Roy A E Bakay; John R Sladek; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2007-01-23       Impact factor: 5.996

2.  Dopaminergic neurons protected from degeneration by GDNF gene therapy.

Authors:  D L Choi-Lundberg; Q Lin; Y N Chang; Y L Chiang; C M Hay; H Mohajeri; B L Davidson; M C Bohn
Journal:  Science       Date:  1997-02-07       Impact factor: 47.728

3.  Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.

Authors:  S Hunot; V Bernard; B Faucheux; F Boissière; E Leguern; C Brana; P P Gautris; J Guérin; B Bloch; Y Agid; E C Hirsch
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

4.  PET studies of functional compensation in a primate model of Parkinson's disease.

Authors:  J L Eberling; K S Bankiewicz; S Jordan; H F VanBrocklin; W J Jagust
Journal:  Neuroreport       Date:  1997-08-18       Impact factor: 1.837

5.  Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability.

Authors:  Nicholas M Kanaan; Jeffrey H Kordower; Timothy J Collier
Journal:  J Comp Neurol       Date:  2007-06-10       Impact factor: 3.215

6.  GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.

Authors:  J L Tseng; E E Baetge; A D Zurn; P Aebischer
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

Review 7.  Nonhuman primate models of Parkinson's disease.

Authors:  Marina E Emborg
Journal:  ILAR J       Date:  2007

Review 8.  Menopause in nonhuman primates?

Authors:  Margaret L Walker; James G Herndon
Journal:  Biol Reprod       Date:  2008-05-21       Impact factor: 4.285

9.  Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys.

Authors:  Nicholas M Kanaan; Jeffrey H Kordower; Timothy J Collier
Journal:  Glia       Date:  2008-08-15       Impact factor: 7.452

Review 10.  Contributions of non-human primates to neuroscience research.

Authors:  John P Capitanio; Marina E Emborg
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

View more
  25 in total

1.  Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine model.

Authors:  Sara E Gombash; Jack W Lipton; Timothy J Collier; Lalitha Madhavan; Kathy Steece-Collier; Allyson Cole-Strauss; Brian T Terpstra; Anne L Spieles-Engemann; Brian F Daley; Susan L Wohlgenant; Valerie B Thompson; Fredric P Manfredsson; Ronald J Mandel; Caryl E Sortwell
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

2.  Aged monkeys as a partial model for Parkinson's disease.

Authors:  P J Hurley; J D Elsworth; M C Whittaker; R H Roth; D E Redmond
Journal:  Pharmacol Biochem Behav       Date:  2011-05-18       Impact factor: 3.533

3.  Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain.

Authors:  Nicole K Polinski; Sara E Gombash; Fredric P Manfredsson; Jack W Lipton; Christopher J Kemp; Allyson Cole-Strauss; Nicholas M Kanaan; Kathy Steece-Collier; Nathan C Kuhn; Susan L Wohlgenant; Caryl E Sortwell
Journal:  Neurobiol Aging       Date:  2014-10-13       Impact factor: 4.673

Review 4.  Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.

Authors:  Delphine Charvin; Rossella Medori; Robert A Hauser; Olivier Rascol
Journal:  Nat Rev Drug Discov       Date:  2018-09-28       Impact factor: 84.694

5.  Intraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primates.

Authors:  Marina E Emborg; Valerie Joers; Ronald Fisher; Kevin Brunner; Victoria Carter; Chris Ross; Raghu Raghavan; Martin Brady; James Raschke; Ken Kubota; Andrew Alexander
Journal:  Cell Transplant       Date:  2010-06-29       Impact factor: 4.064

6.  Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain.

Authors:  Marina E Emborg; Yan Liu; Jiajie Xi; Xiaoqing Zhang; Yingnan Yin; Jianfeng Lu; Valerie Joers; Christine Swanson; James E Holden; Su-Chun Zhang
Journal:  Cell Rep       Date:  2013-03-14       Impact factor: 9.423

7.  Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys.

Authors:  Marina E Emborg; Zhijian Zhang; Valerie Joers; Kevin Brunner; Viktorya Bondarenko; Sachiko Ohshima; Su-Chun Zhang
Journal:  Cell Transplant       Date:  2013       Impact factor: 4.064

8.  Pathways of infusate loss during convection-enhanced delivery into the putamen nucleus.

Authors:  Martin L Brady; Raghu Raghavan; Andrew Alexander; Ken Kubota; Karl Sillay; Marina E Emborg
Journal:  Stereotact Funct Neurosurg       Date:  2013-01-22       Impact factor: 1.875

9.  Efficient Expression of Igf-1 from Lentiviral Vectors Protects In Vitro but Does Not Mediate Behavioral Recovery of a Parkinsonian Lesion in Rats.

Authors:  Ngoc B Lu-Nguyen; Martin Broadstock; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther       Date:  2015-10-01       Impact factor: 5.695

10.  Human neural stem cells survive long term in the midbrain of dopamine-depleted monkeys after GDNF overexpression and project neurites toward an appropriate target.

Authors:  Dustin R Wakeman; D Eugene Redmond; Hemraj B Dodiya; John R Sladek; Csaba Leranth; Yang D Teng; R Jude Samulski; Evan Y Snyder
Journal:  Stem Cells Transl Med       Date:  2014-04-17       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.